Data / Form D filings / Intabio, Inc.
Intabio, Inc.: Form D filings
Intabio, Inc., a biotechnology company in Portola Valley, CA, filed 3 Form D notices with the SEC between 2017 and 2018. The latest, on November 5, 2018, reports $9.2 million sold of a $9.2 million offering to 6 investors.
Find out what Intabio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3130 ALPINE ROAD, #288-124, Portola Valley, CA, 94028
- Phone
- (650) 224-9942
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1709497
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2018 | New notice | $9,225,000 | $9,225,000 | $0 | 6 | Oct 24, 2018 | sec.gov |
| Nov 2, 2018 | Amendment | $3,200,000 | $3,200,000 | $0 | 8 | Jun 7, 2017 | sec.gov |
| Jun 20, 2017 | New notice | $2,000,000 | $851,993 | $1,148,007 | 2 | Jun 7, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Erik Gentalen | Executive Officer, Director | |
| Lena Wu | Executive Officer, Director | |
| Michael Rubin | Director | |
| Jenny Rooke | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Nov 5, 2018 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Intabio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.